李玉军,毕利萍,张洪岩,于晓彬,宋臻,乔宏杰

• 1:中国石油天然气集团公司中心医院放疗科

摘要(Abstract)：

目的观察早期乳腺癌保乳术后全乳大分割照射同步瘤床加量的短期疗效与不良反应。方法 64例早期乳腺癌患者保乳术后行两野切线全乳照射,全乳腺照射40.5 Gy/15 f,单次剂量2.7 Gy/f,同步瘤床推量至48Gy/15 f,单次剂量3.2 Gy/f,总疗程3周,观察分析患者局部复发情况、美容效果及不良反应。结果中位随访时间17月,随访率为100%,无局部复发情况发生。3例患者表现乳腺中度胀痛;Ⅰ、Ⅱ、Ⅲ级急性皮肤反应发生率分别为17.2%、4.7%、1.6%;Ⅰ级血小板下降发生率与Ⅰ~Ⅱ级中性粒细胞减少发生率分别为1.6%、4.7%;放疗完成后4、7月美容优良率分别为90.6%、87.5%。结论早期乳腺癌保乳术后全乳放疗同步瘤床加量的短期疗效与以往常规放疗方式相似,缩短放疗时间,不会增加皮肤不良反应及降低美容效果。

关键词(KeyWords)： 乳腺肿瘤/放射疗法;乳房切除术,区段;乳腺肿瘤/外科学;放射疗法/方法;治疗结果

Abstract:

Keywords:

基金项目(Foundation):

作者(Author): 李玉军,毕利萍,张洪岩,于晓彬,宋臻,乔宏杰

DOI: 10.13267/j.cnki.syzlzz.2017.01.018

参考文献(References)：

• [1]Kawamura M,Itoh Y,Sawaki M,et al.A phaseⅠ/Ⅱtrial of intraoperative breast radiotherapy in an Asian population:5-year results of local control and cosmetic outcome[J].Radiat Oncol,2015,10:150.
• [2]Bartelink H,Maingon P,Poortmans P,et al.Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer:20-year follow-up of a randomised phase 3 trial[J].Lancet Oncol,2015,16(1):47-56.
• [3]楼建军,崔珍,何斌,等.早期乳腺癌术后大分割放射治疗50例临床分析[J].中国现代医学杂志,2015,25(23):103-105.
• [4]侯海玲,朱莉,王平,等.早期乳腺癌保留乳房手术后全乳腺大分割放射治疗与常规分割放射治疗的随机对照研究[J].中华乳腺病杂志(电子版),2015,9(3):163-167.
• [5]Frederick L,Page DL,Fleming ID,et al.AJCC cancer staging manual[M].New York:Springer,2002:82-205.
• [6]Anderson SJ,Wapnir I,Dignam JJ,et al.Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in patients treated by breast-conserving therapy in five National Surgical Adjuvant Breast and Bowel Project protocols of node-negative breast cancer[J].J Clin Oncol,2009,27(15):2466-2473.
• [7]Trotti A,Colevas AD,Setser A,et al.CTCAE v3.0:development of a comprehensive grading system for the adverse effects of cancer treatment[J].Semin Radiat Oncol,2003,13(3):176-181.
• [8]Harris JR,Levene MB,Svensson G,et al.Analysis of cosmetic results following primary radiation therapy for stages I and II carcinoma of the breast[J].Int J Radiat Oncol,1979,5(2):257-261.
• [9]傅燕萍,吴志明,范乘龙,等.Annexin A3在乳腺癌中的表达及临床意义[J].实用肿瘤杂志,2015,30(6):567-570.
• [10]夏冬,李显蓉,姚晖.早期乳腺癌患者行改良根治手术与保乳术的疗效观察[J].实用肿瘤杂志,2012,27(2):133-135.
• [11]START Trialists'Group,Bentzen SM,Agrawal RK,et al.The UK Standardisation of Breast Radiotherapy(START)Trial B of radiotherapy hypofractionation for treatment of early breast cancer:a randomised trial[J].Lancet,2008,371(9618):1098-1107.
• [12]Chadha M,Vongtama D,Friedmann P,et al.Comparative acute toxicity from whole breast irradiation using 3-week accelerated schedule with concomitant boost and the 6.5-week conventional schedule with sequential boost for early-stage breast cancer[J].Clin Breast Cancer,2012,12(1):57-62.
• [13]Osa EO,De Wyngaert K,Roses D,et al.Prone breast intensity modulated radiation therapy:5-year results[J].Int J Radiat Oncol Biol Phys,2014,89(4):899-906.
• [14]Ciervide R,Dhage S,Guth A,et al.Five year outcome of145 patients with ductal carcinoma in situ(DCIS)after accelerated breast radiotherapy[J].Int J Radiat Oncol Biol Phys,2012,83(2):e159-e164.
• [15]Scorsetti M,Alongi F,Fogliata A,et al.PhaseⅠ-Ⅱstudy of hypofractionated simultaneous integrated boost using volumetric modulated arc therapy for adjuvant radiation therapy in breast cancer patients:a report of feasibility and early toxicity results in the first 50 treatments[J].Radiat Oncol,2012,7:145.